tissue plasminogen activator

tissue plasminogen activator

美 　英

  • 網絡組織型纖溶酶原激活劑；組織型纖溶酶原激活物；組織纖維蛋白溶酶原激活劑

英漢解釋

n.

例句

Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review.

急性缺血性卒中患應用重組組織纖溶酶原激活劑治療的效用成本：一項系統性回顧

A drug called tissue plasminogen activator -- tPA -- dissolves clots and restores blood flow.

而一種稱為組織纖維蛋白溶酶原激活物（tPA）的藥物可以溶解血塊，并恢復血液流通。

Because of extensive purpura fulminans with skin necrosis recombinant tissue plasminogen activator (rt-PA) was used.

由于廣泛的暴發性紫癜皮膚壞死與重組組織型纖溶酶原激活劑（酶原激活劑）的使用。

NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.

在兩個試驗中，在組織纖維蛋白溶酶原激活劑使用前，都先用NIHSS評分。

Intravenous thrombolysis therapies in acute myocardial infarction with the reconstructive tissue plasminogen activator in prehospital care

急性心肌梗死院前應用重組組織型纖溶酶原激活劑溶栓研究

Clinical Thrombolytic Trial of A New Type of Tissue-Plasminogen Activator in Patients with Acute Myocardial Infarction

一種新的人組織纖溶酶原激活劑對急性心肌梗死的溶栓效果

Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction

急性腦梗死靜脈溶栓治療的難點與對策

Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction

尿激酶與重組織型纖溶酶原激活劑靜脈溶栓治療急性心肌梗死

The efficacy of thrombolysis with recombinant tissue plasminogen activator as compared with urokinase for acute myocardial infarction

重組組織型纖溶酶原激活劑和尿激酶治療急性心肌梗死的療效比較

Combined intravenous and intra-arterial infusion of recombinant tissue plasminogen activator for treatment of acute ischemic stroke

重組組織型纖溶酶原激活劑動靜脈聯合溶栓治療急性缺血性卒中

Recombinant tissue plasminogen activator for treatment of fibrinous membranes after cataract surgery

重組組織型纖維蛋白酶原激活劑治療白內障手術后的纖維蛋白膜

The mechanism of the regulation of calcium to the expression of tissue plasminogen activator in epidermis

表皮細胞中鈣離子調節組織型纖溶酶原激活劑表達的機制

Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain

組織纖溶酶原激活物溶栓治療缺血性卒中大鼠導致大腦中粘附分子表達改變-評論

Construction of tissue plasminogen activator eukaryotic expression vector and its expression in MCF-7 cell line

組織型纖溶酶原激活劑真核表達載體的構建及其在乳癌細胞系MCF-7中的瞬時表達

The current status and progress of recombinant tissue plasminogen activator for treatment of ischemic stroke

重組組織型纖溶酶原激活劑治療缺血性卒中的現狀與進展

Recovery of blood-nerve barrier is delayed in tissue plasminogen activator gene knockout mice after sciatic nerve crush

組織型纖溶酶原激活劑促進小鼠坐骨神經血-神經屏障損傷后的修復

Vitrectomy combined with tissue plasminogen activator and fraxiparine for fibrin exudation caused by bacterial endophthalmitis in rabbits

玻璃體切割術聯合組織型纖溶酶原激活物和速避凝治療兔細菌性眼內炎所致纖維蛋白滲出

Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse

EGF對小鼠角質形成細胞中組織型纖溶酶原激活劑表達的調節

The regulatory effect of tissue plasminogen activator involved in central nervous insult

組織型纖溶酶原激活物在中樞神經損傷中的調節作用

Nursing care of patients with acute myocardial infarction treated with recombinant human tissue plasminogen activator

重組人組織纖溶酶原激活劑治療急性心肌梗死病人的護理

Expression of tissue plasminogen activator and inhibitor-1 after acute pulmonary thromboembolism in rabbit

肺血栓栓塞后組織型纖溶酶原激活物及其抑制物-1在肺動脈中的表達

The effect of recombinant human tissue plasminogen activator on coagulation function and immune response in pigs

重組人類組織型纖溶酶原激活劑對家豬凝血和免疫指標的影響

R-TPA recombinant tissue plasminogen activator

重組的組織型纖溶酶原激活物

Construction of human tissue plasminogen activator minigene

人組織型纖溶酶原激活劑突變體微小基因的構建

The Study of Relationship between Tissue Plasminogen Activator and Diseases Related to Thrombus

組織型纖溶酶原激活物與血栓相關性疾病的關系研究

The Study on Tissue Plasminogen Activator Change in Stroke Patients

缺血性腦卒中患者血纖溶活性變化規律的研究

Association of Hyperdense Middle Cerebral Artery Sign With Clinical Outcome in Patients Treated With Tissue Plasminogen Activator

中風患者高密度大腦中動脈征象與組織纖溶酶原激活劑治療臨床預后的關系